Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Martin Cannon

Concepts (295)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dendritic Cells
26
2023
133
3.810
 Why?
Ovarian Neoplasms
23
2023
448
3.790
 Why?
Cancer Vaccines
13
2020
78
3.060
 Why?
Immunotherapy
12
2019
240
1.960
 Why?
Th17 Cells
3
2020
25
1.530
 Why?
Antigens, Neoplasm
11
2019
152
1.350
 Why?
CD4-Positive T-Lymphocytes
8
2023
163
1.090
 Why?
Uterine Cervical Neoplasms
13
2011
275
0.980
 Why?
Oncogene Proteins, Viral
7
2011
52
0.830
 Why?
Neoplasm Recurrence, Local
3
2020
633
0.780
 Why?
T-Lymphocytes, Regulatory
6
2011
86
0.740
 Why?
T-Lymphocytes, Cytotoxic
12
2013
65
0.720
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
3
2014
16
0.670
 Why?
Lymphocytes, Tumor-Infiltrating
4
2019
78
0.620
 Why?
Neoplasms
4
2019
1250
0.580
 Why?
CD8-Positive T-Lymphocytes
11
2023
127
0.570
 Why?
Antibodies, Monoclonal
5
2019
461
0.570
 Why?
DNA-Binding Proteins
5
2007
428
0.550
 Why?
Interleukin-17
2
2020
36
0.550
 Why?
p38 Mitogen-Activated Protein Kinases
2
2014
96
0.530
 Why?
Ascites
1
2014
29
0.460
 Why?
T-Lymphocytes
5
2017
339
0.460
 Why?
Immunologic Surveillance
2
2011
10
0.450
 Why?
Female
42
2023
26668
0.410
 Why?
Cytokines
4
2014
615
0.410
 Why?
Signal Transduction
3
2017
1624
0.410
 Why?
Carcinoma
2
2017
139
0.400
 Why?
T-Lymphocytes, Helper-Inducer
2
2011
42
0.390
 Why?
Immunotherapy, Active
1
2011
4
0.390
 Why?
Serine Endopeptidases
3
2009
53
0.380
 Why?
Cytotoxicity, Immunologic
7
2011
56
0.380
 Why?
Humans
52
2023
50251
0.360
 Why?
Adoptive Transfer
1
2009
40
0.330
 Why?
Immunotherapy, Adoptive
3
2005
159
0.330
 Why?
Interferon-gamma
7
2020
176
0.310
 Why?
Epitopes, T-Lymphocyte
3
2008
24
0.300
 Why?
Lymphocyte Activation
3
2005
171
0.280
 Why?
Adjuvants, Immunologic
3
2011
51
0.280
 Why?
Herpesvirus 4, Human
2
2005
35
0.280
 Why?
Papillomavirus Vaccines
1
2007
61
0.280
 Why?
Immunodominant Epitopes
2
2008
8
0.270
 Why?
Dependovirus
3
2011
101
0.240
 Why?
Animals
15
2023
13285
0.240
 Why?
Cell Line, Tumor
12
2017
1418
0.230
 Why?
HLA-A2 Antigen
3
2009
11
0.230
 Why?
Cell Transformation, Viral
1
2003
25
0.220
 Why?
Cell Line, Transformed
1
2003
73
0.220
 Why?
Poxviridae Infections
1
2022
4
0.210
 Why?
Poxviridae
1
2022
7
0.210
 Why?
Myxoma virus
1
2022
14
0.210
 Why?
Interferon Type I
1
2022
25
0.210
 Why?
Cystadenocarcinoma, Serous
5
2009
71
0.200
 Why?
Vaccination
4
2010
273
0.200
 Why?
Papillomavirus E7 Proteins
5
2011
31
0.200
 Why?
Receptor, erbB-2
4
2008
74
0.200
 Why?
Disease-Free Survival
2
2020
454
0.200
 Why?
Interleukin-10
2
2017
84
0.200
 Why?
Genes, MHC Class I
3
2008
11
0.190
 Why?
Testis
2
2011
69
0.190
 Why?
Injections, Intradermal
1
2020
14
0.190
 Why?
Membrane Proteins
4
2011
353
0.180
 Why?
Macrophages
4
2022
364
0.180
 Why?
Immunity, Humoral
1
2020
22
0.180
 Why?
Coculture Techniques
3
2014
146
0.180
 Why?
Folate Receptor 1
1
2020
25
0.180
 Why?
Flow Cytometry
8
2013
478
0.180
 Why?
Cell Movement
2
2019
249
0.180
 Why?
Enzyme-Linked Immunosorbent Assay
2
2013
244
0.170
 Why?
B-Lymphocytes
5
2017
170
0.170
 Why?
Carcinoma, Lewis Lung
1
2019
10
0.170
 Why?
Repressor Proteins
3
2011
153
0.170
 Why?
Self Tolerance
1
2019
1
0.170
 Why?
Costimulatory and Inhibitory T-Cell Receptors
1
2019
1
0.170
 Why?
Melanoma, Experimental
1
2019
45
0.160
 Why?
Aged
12
2020
9427
0.160
 Why?
Transplantation, Autologous
1
2020
470
0.160
 Why?
Cells, Cultured
6
2014
1583
0.150
 Why?
Cytotoxicity Tests, Immunologic
4
2005
27
0.150
 Why?
N-Acetylglucosaminyltransferases
1
2017
16
0.150
 Why?
Programmed Cell Death 1 Receptor
1
2017
39
0.150
 Why?
Middle Aged
16
2020
12234
0.150
 Why?
Mice
8
2023
5770
0.140
 Why?
HLA Antigens
4
2006
53
0.140
 Why?
Receptors, Notch
1
2017
27
0.140
 Why?
Human Umbilical Vein Endothelial Cells
2
2014
90
0.140
 Why?
Neoplastic Stem Cells
1
2017
103
0.140
 Why?
Carcinoma, Papillary
3
2005
49
0.130
 Why?
Poliovirus Vaccine, Oral
2
2005
4
0.130
 Why?
Adult
15
2011
13384
0.130
 Why?
Genetic Vectors
3
2011
125
0.130
 Why?
Poliovirus
2
2005
10
0.120
 Why?
Neoplasm Proteins
1
2017
324
0.120
 Why?
Clinical Trials, Phase I as Topic
1
2015
25
0.120
 Why?
Adenocarcinoma
3
2004
402
0.120
 Why?
Antigen Presentation
5
2009
25
0.120
 Why?
Galectin 3
1
2014
14
0.120
 Why?
Kallikreins
2
2005
18
0.120
 Why?
Neoplasm Invasiveness
3
2017
268
0.120
 Why?
Cystadenocarcinoma, Papillary
2
2005
14
0.120
 Why?
Histocompatibility Antigens Class I
2
2005
44
0.110
 Why?
Peptide Fragments
4
2009
211
0.110
 Why?
Endometrial Neoplasms
2
2005
138
0.110
 Why?
Uterine Neoplasms
2
2005
60
0.110
 Why?
Papillomavirus Infections
3
2011
155
0.110
 Why?
Mutation
1
2019
1296
0.110
 Why?
Mice, Inbred C57BL
3
2017
1823
0.100
 Why?
Intracellular Signaling Peptides and Proteins
2
2022
143
0.100
 Why?
Lymphocytes
1
2013
153
0.100
 Why?
Killer Cells, Natural
4
2005
108
0.100
 Why?
Antigens, Viral
3
2007
44
0.100
 Why?
V-Set Domain-Containing T-Cell Activation Inhibitor 1
1
2011
4
0.100
 Why?
rho GTP-Binding Proteins
1
2011
6
0.100
 Why?
Clonal Anergy
1
2011
13
0.100
 Why?
A Kinase Anchor Proteins
1
2011
2
0.100
 Why?
Calmodulin-Binding Proteins
1
2011
10
0.100
 Why?
Drug Resistance, Neoplasm
5
2017
316
0.100
 Why?
Antigen-Presenting Cells
1
2011
26
0.100
 Why?
Antigens, Surface
1
2011
54
0.090
 Why?
Human papillomavirus 16
1
2011
44
0.090
 Why?
Antineoplastic Agents, Alkylating
1
2011
74
0.090
 Why?
Uterine Cervical Dysplasia
1
2011
49
0.090
 Why?
Immunity, Cellular
2
2008
70
0.090
 Why?
Cyclophosphamide
1
2011
166
0.090
 Why?
Prostate
1
2011
117
0.090
 Why?
Diphosphonates
1
2011
90
0.090
 Why?
Imidazoles
1
2011
128
0.090
 Why?
Phenotype
1
2013
732
0.090
 Why?
Gene Expression Regulation, Neoplastic
4
2011
828
0.090
 Why?
Papillomaviridae
3
2005
102
0.090
 Why?
Gene Expression Profiling
2
2005
1041
0.090
 Why?
Neoplasm Staging
3
2007
747
0.090
 Why?
K562 Cells
2
2008
42
0.080
 Why?
Carrier Proteins
1
2011
307
0.080
 Why?
Tumor Microenvironment
2
2023
233
0.080
 Why?
CA-125 Antigen
1
2008
17
0.080
 Why?
Immediate-Early Proteins
1
2008
19
0.080
 Why?
Cytomegalovirus
1
2008
27
0.080
 Why?
RNA, Messenger
4
2005
1108
0.080
 Why?
Green Fluorescent Proteins
1
2008
91
0.080
 Why?
Interleukin-4
2
2005
43
0.080
 Why?
Antibody Formation
1
2007
51
0.070
 Why?
Antibodies, Viral
1
2007
88
0.070
 Why?
Prostatic Neoplasms
1
2011
394
0.070
 Why?
Amino Acid Sequence
2
2005
587
0.070
 Why?
RNA Interference
2
2017
179
0.070
 Why?
Ovary
3
2017
115
0.070
 Why?
Molecular Sequence Data
2
2005
793
0.070
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
412
0.070
 Why?
Recombinant Proteins
1
2007
489
0.070
 Why?
Hypersensitivity, Delayed
1
2005
21
0.070
 Why?
Neoplasms, Squamous Cell
1
2005
7
0.060
 Why?
Breast Neoplasms
3
2003
1184
0.060
 Why?
Monocytes
2
2022
131
0.060
 Why?
Electroporation
1
2005
18
0.060
 Why?
Poliomyelitis
1
2005
5
0.060
 Why?
Enterotoxins
1
2005
12
0.060
 Why?
Cell Line
4
2010
1024
0.060
 Why?
Gene Transfer Techniques
1
2005
38
0.060
 Why?
Genes, erbB-2
1
2005
8
0.060
 Why?
Interleukin-12
1
2005
31
0.060
 Why?
Immunologic Memory
1
2005
30
0.060
 Why?
Antigens, Heterophile
1
2005
1
0.060
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
594
0.060
 Why?
Plasmodium falciparum
1
2005
19
0.060
 Why?
Malaria, Falciparum
1
2005
14
0.060
 Why?
Endemic Diseases
1
2005
22
0.060
 Why?
Burkitt Lymphoma
1
2005
28
0.060
 Why?
Epstein-Barr Virus Infections
1
2005
30
0.060
 Why?
Gangliosides
1
2004
5
0.060
 Why?
Ascitic Fluid
1
2004
12
0.060
 Why?
Genetic Therapy
1
2005
115
0.060
 Why?
Proteins
2
2005
345
0.060
 Why?
Ovariectomy
1
2004
115
0.060
 Why?
Vaccines, Subunit
1
2004
15
0.060
 Why?
Hysterectomy
1
2004
88
0.060
 Why?
Immunization, Passive
1
2004
28
0.060
 Why?
Clinical Trials as Topic
2
2007
466
0.060
 Why?
Interleukin-6
1
2005
267
0.060
 Why?
Tumor Necrosis Factor-alpha
2
2019
391
0.060
 Why?
Cell Differentiation
2
2004
652
0.060
 Why?
Protein Binding
1
2005
668
0.050
 Why?
Epithelial Cells
1
2005
208
0.050
 Why?
Virus Latency
1
2003
47
0.050
 Why?
Vaccinia virus
1
2022
6
0.050
 Why?
Host Specificity
1
2022
5
0.050
 Why?
Cell Adhesion Molecules
1
2003
89
0.050
 Why?
Cell Communication
1
2003
69
0.050
 Why?
Nucleotidyltransferases
1
2022
14
0.050
 Why?
Mammals
1
2022
58
0.050
 Why?
Tumor Cells, Cultured
4
2003
468
0.050
 Why?
Xenograft Model Antitumor Assays
2
2017
213
0.050
 Why?
Disease Progression
2
2019
827
0.050
 Why?
Rabbits
1
2022
374
0.050
 Why?
Radiotherapy
1
2002
126
0.050
 Why?
Down-Regulation
1
2003
349
0.050
 Why?
Blood Transfusion
1
2002
131
0.050
 Why?
Viral Proteins
1
2022
156
0.050
 Why?
Carcinoma, Squamous Cell
1
2004
322
0.050
 Why?
Immunohistochemistry
4
2005
978
0.050
 Why?
Transcriptome
1
2022
320
0.040
 Why?
Endothelium
1
2019
39
0.040
 Why?
Intercellular Adhesion Molecule-1
1
2019
63
0.040
 Why?
Gene Expression
3
2008
615
0.040
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2004
994
0.040
 Why?
Injections, Intraperitoneal
2
2010
55
0.040
 Why?
Tissue Banks
1
2017
8
0.040
 Why?
Antibodies, Monoclonal, Humanized
3
2004
225
0.040
 Why?
Mice, Inbred NOD
1
2017
96
0.040
 Why?
STAT3 Transcription Factor
1
2017
81
0.040
 Why?
Glycosylation
1
2017
102
0.040
 Why?
Tumor Burden
1
2017
131
0.040
 Why?
RNA, Small Interfering
1
2017
215
0.040
 Why?
Multiple Myeloma
1
2011
2958
0.030
 Why?
Lung Neoplasms
1
2002
609
0.030
 Why?
Protein Processing, Post-Translational
1
2017
170
0.030
 Why?
Kaplan-Meier Estimate
1
2017
465
0.030
 Why?
Survival Analysis
2
2010
666
0.030
 Why?
Apoptosis
2
2014
1115
0.030
 Why?
Pore Forming Cytotoxic Proteins
2
2005
9
0.030
 Why?
Perforin
2
2005
11
0.030
 Why?
Anti-Bacterial Agents
1
2019
745
0.030
 Why?
Neovascularization, Pathologic
1
2014
162
0.030
 Why?
Interleukin-2
2
2003
72
0.030
 Why?
Membrane Glycoproteins
2
2005
247
0.030
 Why?
Vaginal Smears
1
2011
27
0.020
 Why?
Organ Specificity
1
2011
107
0.020
 Why?
Prostate-Specific Antigen
1
2011
47
0.020
 Why?
DNA, Viral
1
2011
134
0.020
 Why?
Time Factors
2
2010
2911
0.020
 Why?
Major Histocompatibility Complex
1
2010
12
0.020
 Why?
Prognosis
2
2005
1959
0.020
 Why?
Transduction, Genetic
1
2008
45
0.020
 Why?
Fluorescent Antibody Technique
1
2008
114
0.020
 Why?
Leukocytes, Mononuclear
1
2008
115
0.020
 Why?
Alphapapillomavirus
1
2007
13
0.020
 Why?
T-Lymphocyte Subsets
1
2007
38
0.020
 Why?
Models, Immunological
1
2007
8
0.020
 Why?
Aged, 80 and over
2
2005
3140
0.020
 Why?
Immune Tolerance
1
2007
95
0.020
 Why?
Adolescent
2
2011
6402
0.020
 Why?
HLA-B Antigens
1
2006
6
0.020
 Why?
Clone Cells
1
2006
78
0.020
 Why?
Immunity, Innate
1
2007
105
0.020
 Why?
Male
3
2011
25483
0.020
 Why?
Claudin-3
1
2005
5
0.020
 Why?
Claudin-4
1
2005
7
0.020
 Why?
Combined Modality Therapy
1
2007
641
0.020
 Why?
Mice, Inbred C3H
1
2005
83
0.020
 Why?
Peptides
1
2006
223
0.020
 Why?
Protein Sorting Signals
1
2005
10
0.020
 Why?
Protein Engineering
1
2005
18
0.020
 Why?
Histocompatibility Antigens Class II
1
2005
36
0.020
 Why?
Species Specificity
1
2005
191
0.020
 Why?
Plasmids
1
2005
163
0.020
 Why?
Mice, SCID
1
2005
177
0.020
 Why?
Protein Folding
1
2005
49
0.020
 Why?
Disease Models, Animal
1
2010
1470
0.020
 Why?
Epithelium
1
2004
65
0.020
 Why?
Endocytosis
1
2005
63
0.010
 Why?
Carboplatin
1
2004
53
0.010
 Why?
Radiotherapy, Adjuvant
1
2004
62
0.010
 Why?
Receptors, Cell Surface
1
2005
125
0.010
 Why?
Paclitaxel
1
2004
85
0.010
 Why?
Transfection
1
2005
355
0.010
 Why?
Antineoplastic Agents, Hormonal
1
2004
49
0.010
 Why?
Polymerase Chain Reaction
1
2005
455
0.010
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2003
12
0.010
 Why?
Tumor Stem Cell Assay
1
2003
17
0.010
 Why?
Proportional Hazards Models
1
2005
407
0.010
 Why?
Cervix Uteri
1
2004
49
0.010
 Why?
Swine
1
2005
403
0.010
 Why?
Up-Regulation
1
2005
452
0.010
 Why?
Kinetics
1
2005
632
0.010
 Why?
Keratinocytes
1
2004
90
0.010
 Why?
Receptors, Interleukin-2
1
2002
7
0.010
 Why?
Lymphocyte Subsets
1
2002
13
0.010
 Why?
Leukocytes
1
2003
67
0.010
 Why?
Receptors, Antigen, T-Cell
1
2003
51
0.010
 Why?
Antigens, CD19
1
2002
25
0.010
 Why?
Cell Culture Techniques
1
2003
99
0.010
 Why?
Receptors, IgG
1
2002
22
0.010
 Why?
Cell Death
1
2003
181
0.010
 Why?
Doxorubicin
1
2004
238
0.010
 Why?
Immunophenotyping
1
2002
110
0.010
 Why?
Cisplatin
1
2004
277
0.010
 Why?
Survival Rate
1
2005
902
0.010
 Why?
Tumor Virus Infections
1
2002
42
0.010
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2002
47
0.010
 Why?
Young Adult
1
2011
4002
0.010
 Why?
Fatal Outcome
1
2002
196
0.010
 Why?
Cell Division
1
2002
295
0.010
 Why?
Case-Control Studies
1
2004
1132
0.010
 Why?
Prospective Studies
1
2004
2379
0.010
 Why?
Risk Factors
1
2004
3608
0.010
 Why?
Antineoplastic Agents
1
2002
1186
0.010
 Why?
Cannon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (295) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (36) people
_
Same Department Expand Description
Search Department